Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism
Top Cited Papers
- 1 June 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 19 (3) , 248-256
- https://doi.org/10.1097/mol.0b013e3282f9b54d
Abstract
Purpose of review Stearoyl-coenzyme A desaturase 1 is a δ-9 fatty acid desaturase that catalyzes the synthesis of monounsaturated fatty acids and has emerged as a key regulator of metabolism. This review evaluates the latest advances in our understanding of the pivotal role of stearoyl-coenzyme A desaturase 1 in health and disease. Recent findings Scd1-deficient mice have reduced lipid synthesis and enhanced lipid oxidation, thermogenesis and insulin sensitivity in various tissues including liver, muscle and adipose tissue due to transcriptional and posttranscriptional effects. These metabolic changes protect Scd1-deficient mice from a variety of dietary, pharmacological and genetic conditions that promote obesity, insulin resistance and hepatic steatosis. Stearoyl-coenzyme A desaturase 1 is required to guard against dietary unsaturated fat deficiency, leptin deficiency-induced diabetes, and palmitate-induced lipotoxic insults in muscle and pancreatic β-cells. Paradoxical observations of increased muscle stearoyl-coenzyme A desaturase 1 during obesity, starvation and exercise raise questions as to the role of stearoyl-coenzyme A desaturase 1 in this tissue. Mice with a liver-specific loss of stearoyl-coenzyme A desaturase 1, and inhibition of stearoyl-coenzyme A desaturase 1 via antisense or RNA interference, recapitulate only a subset of the phenotypes observed in global Scd1 deficiency, indicating the involvement of multiple tissues. Summary Recent studies in humans and animal models have highlighted that modulation of stearoyl-coenzyme A desaturase 1 activity by dietary intervention or genetic manipulation strongly influences several facets of energy metabolism to affect susceptibility to obesity, insulin resistance, diabetes and hyperlipidemia.Keywords
This publication has 90 references indexed in Scilit:
- Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient miceJournal of Lipid Research, 2008
- Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid–induced insulin resistanceJournal of Clinical Investigation, 2007
- Stearoyl-Coenzyme A Desaturase 1 Deficiency Protects against Hypertriglyceridemia and Increases Plasma High-Density Lipoprotein Cholesterol Induced by Liver X Receptor ActivationMolecular and Cellular Biology, 2006
- Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistanceJournal of Clinical Investigation, 2006
- Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissuesBiochemical and Biophysical Research Communications, 2005
- Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primatesBiochemical and Biophysical Research Communications, 2005
- A Plasminogen-like Protein Selectively Degrades Stearoyl-CoA Desaturase in Liver MicrosomesPublished by Elsevier ,2003
- Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1cJournal of Biological Chemistry, 2002
- Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.Proceedings of the National Academy of Sciences, 1996
- Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995